DELTA HEALTH
*News Alert* DELTA HEALTH spotlights its premier, directly managed, multi-specialty, US FDA Phase 2 and pivotal Phase 3 clinical trial investigative sites in Asia
SPEARHEADING MEDICAL INNOVATIONS
The DELTA HEALTH GROUP is an international healthcare conglomerate with a diversified portfolio spanning across four core strategic areas: innovative medical R&D, a global network of dedicated, premier clinical trial investigative sites, international telemedicine services and advanced medical solutions
Overview
Mission & Vision
Founded more than two decades ago with the operation of its own network of successful clinical trial investigative sites in the United States, the DELTA HEALTH GROUP has steadily evolved and expanded its capabilities across clinical drug development and international healthcare.
With a passion for connecting medical innovation to patients, diseases, and treatments, we assist partners across the healthcare sector in optimizing and developing new drugs, biologics, and medical devices aimed at delivering advanced therapies and enhancing patient care.
INTERNATIONAL TELEMEDICINE
Overcoming the barriers of distance and resource limitations, our international teams of distinguished physicians and surgeons continue to provide personalized specialist care for patients from assigned geographic regions around the world.
Medical Innovation
Our "A-Team"
Backed by a time-tested, proven track record spanning over 25+ years, the highly talented and experienced best-in-class specialty providers of the DELTA HEALTH "A-Team" have pioneered medical innovations and led complete clinical development programs culminating in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA) and Health Canada.
These drugs are being used to treat patients in the United States, Canada and a number of other countries around the world.
The DELTA HEALTH “A-Team” takes a pragmatic, hands-on approach, providing direct end-to-end oversight of clinical trials throughout the entire development lifecycle. This comprehensive strategy is pivotal to the success of our clinical development programs and clearly differentiates us from leading global competitors.
Expertise In
Late Stage Clinical Development
What Differentiates Us From Others
Over two decades of in-person, face-to-face interactions and successful working collaboration with various Therapeutic Area Divisions of the United States FDA for clinical phase programs related to drugs, biologics and medical devices has significantly strengthened our expertise in late stage clinical development.
This direct engagement with the US FDA has positioned us among a select group within the healthcare industry and provided a distinct advantage over others—deepening our understanding and strengthening our ability to successfully direct FDA clinical development programs for partner companies.
Clinical Trial Investigative Sites
"Running clinical trials where patient populations are located"
DELTA HEALTH operates a global network of dedicated and strategically located clinical trial investigative sites. These premier, multi-specialty investigative sites with extensive experience in conducting new drug development Phase 2 and pivotal Phase 3 clinical trials are managed by the DELTA HEALTH team of highly skilled specialists whose expertise has been vetted over time by various therapeutic area Divisions of the United States FDA.
Our Unrelenting Commitment To Excellence
Combining a patient-centric approach with an unrelenting commitment to excellence, our expertise in developing and executing end-to-end US FDA new drug development programs and managing global clinical trial sites is built on deep knowledge and hands-on experience acquired from working directly with the FDA and successfully directing numerous Phase 1 through pivotal Phase 3 studies across more than 1,000 clinical programs for drugs, biologics, and medical devices.
Our extensive experience with the U.S. FDA enables us to understand exactly what is required for the success of individual clinical development programs. This insight is particularly valuable in managing studies conducted under the direct supervision of the DELTA HEALTH teams on the ground at our strategically located clinical trial investigative sites.
With an acquired acumen for the US FDA clinical drug development process, the DELTA HEALTH team is a dependable partner to co-develop investigational medical products and advance them through the development cycle to successful regulatory approval.
Cross-Functional Global Teams
-
The DELTA HEALTH global teams include dedicated clinical drug development professionals, clinical trial physician investigators, CT site specialists and drug safety experts
-
The clinical development and clinical trial site teams have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world. Learn More Medical R&D - Global Clinical Trial Investigative Sites
-
The DELTA HEALTH International Telemedicine Division includes U.S. Board Certified Medical and Surgical Specialists, U.K. General Medical Council Specialists and other therapeutic area physicians. Learn More International Telemedicine
-
Our Advisory Board includes prestigious names in the world of medicine, including physicians on the faculty of major hospitals and university medical centers in the United States, Canada and the United Kingdom
-
To complement our international medical teams, DELTA HEALTH is supported by experts from our Advanced Medical Solutions Division